People: Arrowhead Research Corp (ARWR.O)

ARWR.O on Consolidated Issue listed on NASDAQ Capital Market

2.21USD
21 May 2013
Price Change (% chg)

$0.08 (+3.76%)
Prev Close
$2.13
Open
$2.14
Day's High
$2.21
Day's Low
$2.14
Volume
49,491
Avg. Vol
132,793
52-wk High
$4.50
52-wk Low
$1.65

Search Stocks

Frykman, Edward 

Brief Biography

Mr. Edward W. Frykman is Independent Director of Arrowhead Research Corp. He has been a director of the Company since January 2004. Mr. Frykman was an Account Executive with Crowell, Weedon & Co., a position he held from 1992 until 2008 when he retired. Before his service at Crowell, Weedon & Co., Mr. Frykman served as Senior Vice President of L.H. Friend & Co. Both Crowell Weedon & Co. and L.H. Friend & Co. are investment brokerage firms located in Southern California. In addition, Mr. Frykman was a Senior Account Executive with Shearson Lehman Hutton, where he served as the Manager of the Los Angeles Regional Retail Office of E. F. Hutton & Co. Mr. Frykman was a director in Arrowhead’s predecessor company since its inception in May 2003 until January 2004, when he became a director of the Company. Mr. Frykman is also a director of Acacia Research Corporation, a publicly-held corporation based in Newport Beach, California. Mr. Frykman is a director of Arrowhead’s majority-owned subsidiaries Calando Pharmaceuticals, Inc., Ablaris Therapeutics, Inc., and Tego Biosciences Corporation.

Basic Compensation

Total Annual Compensation, Long-Term Incentive Plans, All Other, Fiscal Year Total,
-- -- -- --

Options Compensation

  Quantity Market Value
Excercisable -- --
Unexercisable -- --
Excercised -- --
Search Stocks